Genetic Epidemiology, Translational Neurogenomics, Psychiatric Genetics and Statistical Genetics Laboratories investigate the pattern of disease in families, particularly identical and non-identical twins, to assess the relative importance of genes and environment in a variety of important health problems.
QIMR Home Page
GenEpi Home Page
About GenEpi
Publications
Contacts
Research
Staff Index
Collaborators
Software Tools
Computing Resources
Studies
Search
GenEpi Intranet
PMID
21364883
TITLE
Deep sequencing of the Nicastrin gene in pooled DNA, the identification of genetic variants that affect risk of Alzheimer's disease.
ABSTRACT
Nicastrin is an obligatory component of the γ-secretase; the enzyme complex that leads to the production of Aβ fragments critically central to the pathogenesis of Alzheimer's disease (AD). Analyses of the effects of common variation in this gene on risk for late onset AD have been inconclusive. We investigated the effect of rare variation in the coding regions of the Nicastrin gene in a cohort of AD patients and matched controls using an innovative pooling approach and next generation sequencing. Five SNPs were identified and validated by individual genotyping from 311 cases and 360 controls. Association analysis identified a non-synonymous rare SNP (N417Y) with a statistically higher frequency in cases compared to controls in the Greek population (OR 3.994, CI 1.105-14.439, p = 0.035). This finding warrants further investigation in a larger cohort and adds weight to the hypothesis that rare variation explains some of genetic heritability still to be identified in Alzheimer's disease.
DATE PUBLISHED
2011
HISTORY
PUBSTATUS PUBSTATUSDATE
received 2010/11/02
accepted 2011/01/27
epublish 2011/02/25
entrez 2011/03/03 06:00
pubmed 2011/03/03 06:00
medline 2011/09/02 06:00
AUTHORS
NAME COLLECTIVENAME LASTNAME FORENAME INITIALS AFFILIATION AFFILIATIONINFO
Lupton MK Lupton Michelle K MK MRC Centre for Neurodegeneration Research, Institute of Psychiatry, King's College London, London, United Kingdom.
Proitsi P Proitsi Petroula P
Danillidou M Danillidou Makrina M
Tsolaki M Tsolaki Magda M
Hamilton G Hamilton Gillian G
Wroe R Wroe Richard R
Pritchard M Pritchard Megan M
Lord K Lord Kathryn K
Martin BM Martin Belinda M BM
Kloszewska I Kloszewska Iwona I
Soininen H Soininen Hilkka H
Mecocci P Mecocci Patrizia P
Vellas B Vellas Bruno B
Harold D Harold Denise D
Hollingworth P Hollingworth Paul P
Lovestone S Lovestone Simon S
Powell JF Powell John F JF
INVESTIGATORS
JOURNAL
VOLUME: 6
ISSUE: 2
TITLE: PloS one
ISOABBREVIATION: PLoS ONE
YEAR: 2011
MONTH:
DAY:
MEDLINEDATE:
SEASON:
CITEDMEDIUM: Internet
ISSN: 1932-6203
ISSNTYPE: Electronic
MEDLINE JOURNAL
MEDLINETA: PLoS One
COUNTRY: United States
ISSNLINKING: 1932-6203
NLMUNIQUEID: 101285081
PUBLICATION TYPE
PUBLICATIONTYPE TEXT
Journal Article
Research Support, Non-U.S. Gov't
COMMENTS AND CORRECTIONS
REFTYPE REFSOURCE REFPMID NOTE
Cites Nature. 2000 Sep 7;407(6800):48-54 10993067
Cites Neurobiol Aging. 2011 Mar;32(3):434-42 19386383
Cites Am J Hum Genet. 2002 Jun;70(6):1568-74 11992262
Cites Neurosci Lett. 2003 Dec 15;353(1):61-5 14642438
Cites Neurosci Lett. 2003 Dec 19;353(2):153-5 14664923
Cites Neurosci Lett. 2004 Jun 3;363(1):49-53 15157994
Cites Neurology. 2004 Jul 13;63(1):173-5 15249634
Cites J Psychiatr Res. 1975 Nov;12(3):189-98 1202204
Cites Neurology. 1984 Jul;34(7):939-44 6610841
Cites Science. 1995 Aug 18;269(5226):973-7 7638622
Cites Nature. 1995 Aug 31;376(6543):775-8 7651536
Cites Neurosci Lett. 2005 Jan 10;373(2):110-4 15567563
Cites Cell. 2005 Aug 12;122(3):435-47 16096062
Cites Curr Alzheimer Res. 2008 Apr;5(2):132-46 18393798
Cites Nat Methods. 2008 Oct;5(10):887-93 18794863
Cites Genome Res. 2008 Nov;18(11):1851-8 18714091
Cites Nucleic Acids Res. 2008 Nov;36(19):e122 18753151
Cites Nat Methods. 2009 Apr;6(4):263-5 19252504
Cites Science. 2009 Apr 17;324(5925):387-9 19264985
Cites Neurosci Lett. 2009 Jul 24;458(3):136-9 19394408
Cites Neurobiol Aging. 2009 Jul;30(7):1037-47 19362756
Cites Genome Res. 2009 Jul;19(7):1254-61 19447964
Cites Genome Res. 2009 Jul;19(7):1243-53 19447965
Cites Bioinformatics. 2009 Sep 1;25(17):2283-5 19542151
Cites Nat Genet. 2009 Oct;41(10):1088-93 19734902
Cites Nat Genet. 2009 Oct;41(10):1094-9 19734903
Cites N Engl J Med. 2009 Oct 22;361(17):1651-61 19846850
Cites Ann N Y Acad Sci. 2009 Oct;1180:36-46 19906259
Cites Eur J Neurosci. 2009 Nov;30(9):1831-6 19840113
Cites Hum Mutat. 2009 Dec;30(12):1703-12 19842214
Cites Bioinformatics. 2010 Jun 15;26(12):i318-24 20529923
Cites Genet Epidemiol. 2010 Jul;34(5):492-501 20578089
Cites J Hum Genet. 2010 Jul;55(7):448-55 20485446
Cites Science. 2010 Nov 19;330(6007):1065 20929727
Cites Hum Mol Genet. 2001 Mar 15;10(6):591-7 11230178
GRANTS
GENERAL NOTE
KEYWORDS
MESH HEADINGS
DESCRIPTORNAME QUALIFIERNAME
Aged
Aged, 80 and over
Alzheimer Disease genetics
Amyloid Precursor Protein Secretases genetics
Case-Control Studies genetics
DNA analysis
Gene Frequency analysis
Genetic Predisposition to Disease analysis
Genetic Variation physiology
High-Throughput Nucleotide Sequencing methods
Humans methods
Membrane Glycoproteins genetics
Meta-Analysis as Topic genetics
Middle Aged genetics
Polymorphism, Single Nucleotide physiology
Risk Factors physiology
Specimen Handling methods
Validation Studies as Topic methods
SUPPLEMENTARY MESH
GENE SYMBOLS
CHEMICALS
REGISTRYNUMBER NAMEOFSUBSTANCE
0 Membrane Glycoproteins
0 nicastrin protein
9007-49-2 DNA
EC 3.4.- Amyloid Precursor Protein Secretases
OTHER ID's
OTHERID SOURCE
PMC3045431 NLM